Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Eli Lilly and Company (NYSE: LLY) announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study ...

The Alzheimer’s Association has issued its first clinical practice guideline on the use of blood tests to help diagnose ...

The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, ...

Cognition Therapeutics’ therapy showed up to a 129% slowing of cognitive decline in mild Alzheimer’s disease patients.

TORONTO -- Blood tests for Alzheimer's disease biomarkers can be used clinically -- and can replace expensive brain scans and ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

A NEW “game-changing” drug could stop the progression of Alzheimer’s disease, early trials suggest. Scientists say the ...

New tests and new treatments are presenting more options for certain patients with Alzheimer's disease. “Today a confluence ...

JUST off the press this May 2025 is a revolutionary book on Alzheimer’s disease called "Alzheimer’s: Prevention Is the Cure." ...